TOCQUEVILLE ASSET MANAGEMENT L.P. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 139 filers reported holding ACCELERON PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$344,000
+37.1%
2,0000.0%0.01%
+25.0%
Q2 2021$251,000
-7.4%
2,0000.0%0.00%0.0%
Q1 2021$271,000
+5.9%
2,0000.0%0.00%0.0%
Q4 2020$256,000
+13.8%
2,0000.0%0.00%0.0%
Q3 2020$225,000
-83.2%
2,000
-94.9%
0.00%
-50.0%
Q2 2016$1,342,000
+163.1%
39,500
+104.4%
0.01%
+14.3%
Q1 2016$510,000
-7.6%
19,325
+70.6%
0.01%0.0%
Q4 2015$552,000
+95.7%
11,3250.0%0.01%
+75.0%
Q3 2015$282,000
-21.2%
11,3250.0%0.00%0.0%
Q2 2015$358,000
-18.8%
11,325
-2.2%
0.00%
-20.0%
Q1 2015$441,000
-2.2%
11,5750.0%0.01%0.0%
Q4 2014$451,000
+47.9%
11,575
+14.9%
0.01%
+66.7%
Q3 2014$305,000
-30.0%
10,075
-21.4%
0.00%
-25.0%
Q2 2014$436,000
-11.7%
12,825
-10.5%
0.00%
-42.9%
Q1 2014$494,000
+31.4%
14,325
+50.8%
0.01%
+40.0%
Q4 2013$376,0009,5000.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders